|
| | Publication Year | Title | Author(s) |
| 141 | Apr-2022 | Molecular profiling reveals features of clinical immunity and immunosuppression in asymptomatic P. falciparum malaria. | Studniberg, Stephanie I; Ioannidis, Lisa J; Utami, Retno A S; Trianty, Leily; Liao, Yang; Abeysekera, Waruni; Li-Wai-Suen, Connie S N; Pietrzak, Halina M; Healer, Julie; Puspitasari, Agatha M; Apriyanti, Dwi; Coutrier, Farah; Poespoprodjo, Jeanne R; Kenangalem, Enny; Andries, Benediktus; Prayoga, Pak; Sariyanti, Novita; Smyth, Gordon K; Cowman, Alan F; Price, Ric N; Noviyanti, Rintis; Shi, Wei; Garnham, Alexandra L; Hansen, Diana S |
| 142 | Apr-2022 | Correction: Resident and migratory adipose immune cells control systemic metabolism and thermogenesis. | Man, Kevin; Kallies, Axel; Vasanthakumar, Ajithkumar |
| 143 | 30-Mar-2022 | Impact of gene annotation choice on the quantification of RNA-seq data. | Chisanga, David; Liao, Yang; Shi, Wei |
| 144 | 23-Mar-2022 | R code and downstream analysis objects for the scRNA-seq atlas of normal and tumorigenic human breast tissue. | Chen, Yunshun; Pal, Bhupinder; Lindeman, Geoffrey J; Visvader, Jane E; Smyth, Gordon K |
| 145 | 11-Mar-2022 | Radiolabeled Antibodies for Cancer Imaging and Therapy. | Parakh, Sagun ; Lee, Sze Ting ; Gan, Hui K ; Scott, Andrew M |
| 146 | 7-Mar-2022 | Recurrent testicular torsion post orchidopexy - an occult emergency: a systematic review. | van Welie, Mikayla; Qu, Liang G ; Adam, Ahmed; Lawrentschuk, Nathan; Laher, Abdullah E |
| 147 | 3-Mar-2022 | The RNA-binding protein SRSF3 has an essential role in megakaryocyte maturation and platelet production. | Heazlewood, Shen Y; Ahmad, Tanveer; Mohenska, Monika; Guo, Belinda B; Gangatirkar, Pradnya; Josefsson, Emma C; Ellis, Sarah L; Ratnadiwakara, Madara; Cao, Huimin; Cao, Benjamin; Heazlewood, Chad K; Williams, Brenda; Fulton, Madeline; White, Jacinta F; Ramialison, Mirana; Nilsson, Susan K; Änkö, Minna-Liisa |
| 148 | Mar-2022 | Automated processing of solid target 86Y using enriched SrO powder. | Dinh, Thien; Panopoulos, Harris; Poniger, Stan ; Scott, Andrew M |
| 149 | 10-Feb-2022 | Limited-stage Diffuse Large B-cell Lymphoma. | Hawkes, Eliza A ; Barraclough, Allison ; Sehn, Laurie H |
| 150 | Feb-2022 | Radiotherapy planning of lymphomas: role of metabolic imaging with PET/CT. | McKay, Michael J; Taubman, Kim L; Lee, Sze Ting ; Scott, Andrew M |
| 151 | Feb-2022 | Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis. | Goldinger, Simone M; Buder-Bakhaya, Kristina; Lo, Serigne N; Forschner, Andrea; McKean, Meredith; Zimmer, Lisa; Khoo, Chloe; Dummer, Reinhard; Eroglu, Zeynep; Buchbinder, Elizabeth I; Ascierto, Paolo A; Gutzmer, Ralf; Rozeman, Elisa A; Hoeller, Christoph; Johnson, Douglas B; Gesierich, Anja; Kölblinger, Peter; Bennannoune, Naima; Cohen, Justine V; Kähler, Katharina C; Wilson, Melissa A; Cebon, Jonathan S ; Atkinson, Victoria; Smith, Jessica L; Michielin, Olivier; Long, Georgina V; Hassel, Jessica C; Weide, Benjamin; Haydu, Lauren E; Schadendorf, Dirk; McArthur, Grant; Ott, Patrick A; Blank, Christian; Robert, Caroline; Sullivan, Ryan; Hauschild, Axel; Carlino, Matteo S; Garbe, Claus; Davies, Michael A; Menzies, Alexander M |
| 152 | Feb-2022 | Combined Treatment with a WNT Inhibitor and the NSAID Sulindac Reduces Colon Adenoma Burden in Mice with Truncated APC. | Faux, Maree C; Weinstock, Janet; Gogos, Sophia; Prato, Emma; Azimpour, Alexander I; O'Keefe, Ryan; Cathcart-King, Yasmin; Garnham, Alexandra L; Ernst, Matthias ; Preaudet, Adele; Christie, Michael; Putoczki, Tracy L; Buchert, Michael ; Burgess, Antony W |
| 153 | 24-Jan-2022 | VEGF-A, VEGFR1 and VEGFR2 single nucleotide polymorphisms and outcomes from the AGITG MAX trial of capecitabine, bevacizumab and mitomycin C in metastatic colorectal cancer. | Chionh, Fiona; Gebski, Val; Al-Obaidi, Sheren J; Mooi, Jennifer K ; Bruhn, Maressa A; Lee, Chee K; Chüeh, Anderly C; Williams, David S ; Weickhardt, Andrew J ; Wilson, Kate; Scott, Andrew M ; Simes, John; Hardingham, Jennifer E; Price, Timothy J; Mariadason, John M ; Tebbutt, Niall C |
| 154 | 24-Jan-2022 | Longitudinal Monitoring of Intra-Tumoural Heterogeneity Using Optical Barcoding of Patient-Derived Colorectal Tumour Models. | Shembrey, Carolyn; Smith, Jai; Grandin, Mélodie; Williams, Nathalia; Cho, Hyun-Jung; Mølck, Christina; Behrenbruch, Corina; Thomson, Benjamin Nj; Heriot, Alexander G; Merino, Delphine; Hollande, Frédéric |
| 155 | 15-Jan-2022 | Single-Cell Transcriptomics Reveals Discrete Steps in Regulatory T Cell Development in the Human Thymus. | Morgana, Florencia; Opstelten, Rianne; Slot, Manon C; Scott, Andrew M ; van Lier, René A W; Blom, Bianca; Mahfouz, Ahmed; Amsen, Derk |
| 156 | 15-Jan-2022 | STAT3 Signaling in Breast Cancer: Multicellular Actions and Therapeutic Potential. | To, Sarah Q; Dmello, Rhynelle S; Richards, Anna K; Ernst, Matthias ; Chand, Ashwini L |
| 157 | 6-Jan-2022 | Onco-miR-21 Promotes Stat3-Dependent Gastric Cancer Progression. | Tse, Janson; Pierce, Thomas; Carli, Annalisa L E; Alorro, Mariah G; Thiem, Stefan; Marcusson, Eric G; Ernst, Matthias ; Buchert, Michael |
| 158 | Jan-2022 | Can preclinical drug development help to predict adverse events in clinical trials? | Chi, Lap Hing; Burrows, Allan D; Anderson, Robin L |
| 159 | 2022 | Impact of 18F-FDG PET/CT on treatment of patients with differentiated thyroid carcinoma, negative 131I whole body scan and elevated serum thyroglobulin. | Boktor, Raef R; Lee, Sze Ting ; Berlangieri, Salvatore U ; Scott, Andrew M |
| 160 | 2022 | Recruitment, outcomes, and toxicity trends in phase I oncology trials: Six-year experience in a large institution. | Menon, Siddharth; Davies, Amy; Frentzas, Sophia; Hawkins, Cheryl-Ann; Segelov, Eva; Day, Daphne; Markman, Ben |
